Evidence map›Paper›PMID 41189075›Full record

ReviewImmunological reviews2025

Extrafollicular B Cell Responses-Is One Tent Big Enough?

Nicole Baumgarth

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Reversing pregnancy-induced B cell sensitization to facilitate the induction of transplant tolerance in postpartum recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nicole BaumgarthW. Harry Feinstone Department of Molecular Microbiology & Immunology, Lyme and Tickborne Diseases Research and Education Institute, Bloomberg School of Public Health and Department of Molecular and Comparative Pathobiology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-2891-4483

Funding

Antibody-mediated immunity to Borrelia burgdorferiR01AI157007 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAUMGARTH, NICOLE · 2021 to 2025
$2.4M
Extrafollicular B cell response regulation during influenza infectionR01AI184867 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Nicole Baumgarth · 2024 to 2026
$1.8M
Assessing functional immunity to influenza infection by quantifying BCR binding aviditiesR01AI183645 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Nicole Baumgarth, Steven CARL George · 2025 to 2026
$1.6M
NIAID NIH HHS R01 AI157007NIAID NIH HHS R01 AI183645NIAID NIH HHS R01 AI184867Office of Extramural Research, National Institutes of Health R01AI157007Office of Extramural Research, National Institutes of Health R01AI183645Office of Extramural Research, National Institutes of Health R01AI184867
6 · The paper itself

Abstract

Initial description of extrafollicular B cell responses (EF) identified them as short-lived clusters of rapidly proliferating B cells and plasmablasts in splenic bridging channels and red pulp as well as lymph node medullary cord areas. Their physical location guided the nomenclature: outside, or at the edges of B cell follicles and near T cell zones of secondary lymphoid organs, thus distinct from the follicular situated germinal centers (GCs). Because EFs are often induced transiently and to both T-dependent and T-independent antigens, and because they generate IgM and class-switched antibodies often with no or little signs of somatic hypermutations, they were thought to be less impactful than GC-derived antibodies. However, highly protective antibodies are generated by these EFs rapidly after acute infections and their induction often correlates with pathogen clearance, while in autoimmunity EF-derived antibodies have been implicated as pathogenic drivers of disease. Moreover, subsets of memory B cells, including some CD11c+ "atypical" B cells/ABCs are generated independently of GC. Their diverse appearance and impact have initiated an ongoing debate about whether all "non-GC responses" are necessarily EF responses. The current debate is reflected also in the articles compiled for this issue of Immunological Reviews considering EF responses. Here, I briefly summarize the steps leading to B cell activation and EF and GC formation, providing context for the contributed reviews that span a breadth of topics from descriptions of non-GC responses in jawed non-mammalian vertebrates as possible orthologues of mammalian EF to the molecular and metabolic requirements and CD4 T cell helper quality of EF, tissue-specific B cell responses, and discussions on the origins and classifications of "atypical" memory B cells in mice and man.

Indexed as

B-LymphocytesGerminal CenterAnimalsAutoimmunityHumansImmunologic MemoryLymphocyte ActivationMemory B Cells

Identifiers

PMID41189075
PMCPMC12632143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.